Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids

ConclusionsNew persistent opioid use is common in IBD patients who experience a flare, especially among those with mental health disorders, COPD, and Crohn's disease or indeterminate colitis. These findings can be helpful in risk ‐stratifying patients when choosing an acute pain therapy and providing counselling before choosing to prescribe opioids to opioid‐naïve patients experiencing an IBD flare.

https://onlinelibrary.wiley.com/doi/abs/10.1111/apt.15023?af=R

Source: Alimentary Pharmacology and Therapeutics - November 14, 2018 Category: Drugs & Pharmacology Authors: Mohamed Noureldin, Peter D. R. Higgins, Shail M. Govani, Shirley Cohen ‐Mekelburg, Brooke C. Kenney, Ryan W. Stidham, Jennifer F. Waljee, Akbar K. Waljee Tags: ORIGINAL ARTICLE Source Type: research